UBS O'Connor’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $646K | Buy |
27,400
+4,875
| +22% | +$115K | 0.03% | 238 |
|
|
2025
Q1 | $541K | Buy |
22,525
+10,994
| +95% | +$264K | 0.02% | 202 |
|
|
2024
Q4 | $488K | Sell |
11,531
-19,921
| -63% | -$842K | 0.01% | 275 |
|
|
2024
Q3 | $1.39M | Sell |
31,452
-7,964
| -20% | -$352K | 0.03% | 233 |
|
|
2024
Q2 | $1.43M | Buy |
39,416
+11,850
| +43% | +$429K | 0.04% | 242 |
|
|
2024
Q1 | $1.19M | Sell |
27,566
-79,406
| -74% | -$3.42M | 0.03% | 255 |
|
|
2023
Q4 | $1.65M | Sell |
106,972
-71,019
| -40% | -$1.09M | 0.05% | 204 |
|
|
2023
Q3 | $2.44M | Buy |
177,991
+50,000
| +39% | +$686K | 0.04% | 210 |
|
|
2023
Q2 | $2.05M | Sell |
127,991
-95,477
| -43% | -$1.53M | 0.04% | 285 |
|
|
2023
Q1 | $1.73M | Buy |
+223,468
| New | +$1.73M | 0.04% | 343 |
|